BBOT vs FSLR · rev $7.5M vs P/E 16, rev $2.10B
BridgeBio Oncology Therapeutics, Inc. (BBOT) versus First Solar Inc (FSLR) — a side-by-side from cached financials, not a winner call.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
First Solar Inc (FSLR) is a solar company listed on NASDAQ. It is led by Mark R. Widmar.
Latest reported BBOT revenue for 2026-06-30 was $7.5M. Net income was -$98.6M. Revenue was up 90.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.
Latest reported FSLR revenue for 2026-06-30 was $2.10B. Net income was $769.2M. FSLR currently screens at market cap $27.38B and trailing P/E 16.4.
BBOT currently screens at market cap $610.4M. FSLR currently screens at market cap $27.38B and trailing P/E 16.4.
Not investment advice. Open the BBOT and FSLR stock pages for the full models.
Not investment advice.